Is TRUL.CN undervalued or overvalued?
As of 2025-03-19, the Intrinsic Value of Trulieve Cannabis Corp (TRUL.CN) is 0.93 CAD. This TRUL.CN valuation is based on the model Discounted Cash Flows (EBITDA Exit 10Y). With the current market price of 5.96 CAD, the upside of Trulieve Cannabis Corp is -84.30%. This means that TRUL.CN is overvalued by 84.30%.
The range of the Intrinsic Value is (8.53) - 33.04 CAD
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (117.84) - (12.91) | (20.70) | -447.3% |
| DCF (Growth 10y) | (21.45) - (318.23) | (42.03) | -805.2% |
| DCF (EBITDA 5y) | (4.82) - 3.89 | (1,773.85) | -123450.0% |
| DCF (EBITDA 10y) | (8.53) - 33.04 | 0.93 | -84.3% |
| Fair Value | -4.84 - -4.84 | -4.84 | -181.25% |
| P/E | (18.83) - (20.80) | (19.54) | -427.9% |
| EV/EBITDA | 15.87 - 74.24 | 42.25 | 608.9% |
| EPV | (0.06) - 9.08 | 4.51 | -24.3% |
| DDM - Stable | (9.12) - (36.90) | (23.01) | -486.0% |
| DDM - Multi | (16.44) - (52.30) | (25.09) | -520.9% |
| Market Cap (mil) | 1,138.42 |
| Beta | 0.61 |
| Outstanding shares (mil) | 191.01 |
| Enterprise Value (mil) | 1,796.56 |
| Market risk premium | 5.10% |
| Cost of Equity | 8.90% |
| Cost of Debt | 30.46% |
| WACC | 15.91% |